Pfizer Net Worth 2012-2025 | PFE
Interactive chart of historical net worth (market cap) for Pfizer (PFE) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Pfizer net worth as of January 13, 2026 is $143B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Large Cap Pharmaceutical | $142.996B | $63.627B |
| Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eli Lilly (LLY) | United States | $1018.358B | 48.99 |
| Johnson & Johnson (JNJ) | United States | $514.746B | 20.58 |
| AbbVie (ABBV) | United States | $390.150B | 23.36 |
| Roche Holding AG (RHHBY) | Switzerland | $339.804B | 0.00 |
| Novartis AG (NVS) | Switzerland | $299.140B | 15.86 |
| Merck (MRK) | United States | $268.704B | 12.52 |
| Novo Nordisk (NVO) | Denmark | $266.293B | 15.61 |
| Sanofi (SNY) | France | $115.121B | 11.13 |
| Bayer (BAYRY) | Germany | $44.563B | 7.82 |
| Innoviva (INVA) | United States | $1.459B | 7.31 |